Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-15

Clinical Trial Update: Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients [NA]

View source ↗

Summary

A clinical trial compares Engerix-B and Sci-B-Vac hepatitis B vaccines in patients with celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Engerix-B (hepatitis B vaccine)
  • Sci-B-Vac (hepatitis B vaccine (recombinant))

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Celiac Disease | NA | Status: UNKNOWN